These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19786831)

  • 1. Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal.
    Zhang Q; Yang W; Man N; Zheng F; Shen Y; Sun K; Li Y; Wen LP
    Autophagy; 2009 Nov; 5(8):1107-17. PubMed ID: 19786831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C60(Nd) nanoparticles enhance chemotherapeutic susceptibility of cancer cells by modulation of autophagy.
    Wei P; Zhang L; Lu Y; Man N; Wen L
    Nanotechnology; 2010 Dec; 21(49):495101. PubMed ID: 21071824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles.
    Hu Y; Zhang HR; Dong L; Xu MR; Zhang L; Ding WP; Zhang JQ; Lin J; Zhang YJ; Qiu BS; Wei PF; Wen LP
    Nanoscale; 2019 Jun; 11(24):11789-11807. PubMed ID: 31184642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C60 fullerene-pentoxifylline dyad nanoparticles enhance autophagy to avoid cytotoxic effects caused by the β-amyloid peptide.
    Lee CM; Huang ST; Huang SH; Lin HW; Tsai HP; Wu JY; Lin CM; Chen CT
    Nanomedicine; 2011 Feb; 7(1):107-14. PubMed ID: 20620236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pristine C
    Demir E; Nedzvetsky VS; Ağca CA; Kirici M
    Neurochem Res; 2020 Oct; 45(10):2385-2397. PubMed ID: 32712876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
    Isakovic A; Markovic Z; Todorovic-Markovic B; Nikolic N; Vranjes-Djuric S; Mirkovic M; Dramicanin M; Harhaji L; Raicevic N; Nikolic Z; Trajkovic V
    Toxicol Sci; 2006 May; 91(1):173-83. PubMed ID: 16476688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy.
    Shi J; Liu Y; Wang L; Gao J; Zhang J; Yu X; Ma R; Liu R; Zhang Z
    Acta Biomater; 2014 Mar; 10(3):1280-91. PubMed ID: 24211343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
    Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
    J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation and Evaluation of Fullerene Based Nanomedicine].
    Iohara D
    Yakugaku Zasshi; 2019; 139(12):1539-1546. PubMed ID: 31787641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts.
    Liao F; Saitoh Y; Miwa N
    Oncol Res; 2011; 19(5):203-16. PubMed ID: 21542456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of dextran stabilized fullerene C
    Biby TE; Prajitha N; Ashtami J; Sakthikumar D; Maekawa T; Mohanan PV
    Brain Res Bull; 2020 Feb; 155():191-201. PubMed ID: 31786269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
    Skariyachan S; Parveen A; Garka S
    J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of water-soluble fullerene in vascular endothelial cells.
    Yamawaki H; Iwai N
    Am J Physiol Cell Physiol; 2006 Jun; 290(6):C1495-502. PubMed ID: 16407415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.
    Prylutska S; Grynyuk I; Matyshevska O; Prylutskyy Y; Evstigneev M; Scharff P; Ritter U
    Drugs R D; 2014 Dec; 14(4):333-40. PubMed ID: 25504158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytotoxicity of photoexcited fullerene C60 and cisplatin combination against drug-resistant leukemic cells.
    Franskevych DV; Prylutska SV; Grynyuk II; Grebinyk DM; Matyshevska OP
    Exp Oncol; 2015 Sep; 37(3):187-91. PubMed ID: 26422102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C
    Hurmach Y; Rudyk M; Prylutska S; Hurmach V; Prylutskyy YI; Ritter U; Scharff P; Skivka L
    Mol Pharm; 2020 Sep; 17(9):3622-3632. PubMed ID: 32673486
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of cisplatin-induced reactive oxygen species production by fullerene C(60) in normal and transformed lymphoid cells.
    Franskevych DV; Grynyuk II; Prylutska SV; Matyshevs ka OP
    Ukr Biochem J; 2016; 88(1):44-50. PubMed ID: 29227077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fullerene C₆₀ nanoparticles on A549 cells.
    Wang F; Jin C; Liang H; Tang Y; Zhang H; Yang Y
    Environ Toxicol Pharmacol; 2014 Mar; 37(2):656-61. PubMed ID: 24577232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles.
    Sayes CM; Marchione AA; Reed KL; Warheit DB
    Nano Lett; 2007 Aug; 7(8):2399-406. PubMed ID: 17630811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
    Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
    Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.